You are here: Industry Insights > Cleveland Clinic

News List

Cleveland Clinic launches first-of-its kind preventive breast cancer vaccine study WorldPharmaNews
November 03, 2021
Cleveland Clinic researchers have opened a novel study for a vaccine aimed at eventually preventing triple-negative breast cancer, the most aggressive and lethal form of the disease.
Study identifies how COVID-19 linked to Alzheimer's disease-like cognitive impairment worldpharmanews
June 16, 2021
A new Cleveland Clinic-led study has identified mechanisms by which COVID-19 can lead to Alzheimer's disease-like dementia. The findings, published in Alzheimer's Research & Therapy, indicate an overlap between COVID-19 and brain changes common in ...
Nanoparticle-delivered COVID-19 vaccine candidate shows promise in preclinical studies worldpharmanews
March 04, 2021
Researchers from Cleveland Clinic's Global Center for Pathogen Research & Human Health have developed a promising new COVID-19 vaccine candidate that utilizes nanotechnology and has shown strong efficacy in preclinical disease models.
Anixa, Cleveland Clinic Announce FDA Clearance to Initiate Breast Cancer Vaccine Trial americanpharmaceuticalreview
January 08, 2021
Anixa Biosciences announced the U.S. Food and Drug Administration (FDA) has cleared the Investigational New Drug (IND) application for its breast cancer vaccine.
AITRICS and Cleveland Clinic collaborate to verify AI-based sepsis prediction solution prnasia
April 14, 2020
AITRICS, a Korea-based startup offering AI solutions, has signed a joint research agreement with Cleveland Clinic, a general hospital located in Cleveland, Ohio.
Cleveland Clinic researchers discover a new diet-associated gut-microbe metabolite linked to cardiovascular disease expresspharma
March 17, 2020
Discovery could help explain why beta-blockers are effective in treating heart disease patients.
Luye Medical, Cleveland Clinic to build unit in China biospectrumasia
September 23, 2019
Shanghai Luye Lilan Hospital, a Cleveland Clinic Connected project, will be open for patients in 2024.
Anixa Biosciences Announces Agreement with Cleveland Clinic americanpharmaceuticalreview
July 18, 2019
Anixa Biosciences has established a strategic alliance and license agreement with Cleveland Clinic for breast cancer vaccine technology.